Methamphetamine Dependence
Conditions
Brief summary
The purpose of this study is to develop the technology infrastructure for a mobile Web-based cognitive and neuropsychological assessment of substance abusers, and to perform a pilot trial using neurocognitive tasks designed to demonstrate that our system is statistically comparable to current clinical practice. The primary hypotheses are that results collected using a web-based data collection platform will be comparable (but not necessarily equivalent) to data collected under controlled laboratory conditions, that methamphetamine (MA) dependent participants will have worsened neurocognitive performance compared to healthy volunteers, and the platform will be acceptable to participants.
Interventions
DEVICEWeb-Enabled Cognitive Neuropsychological Evaluation System
Sponsors
Creare, Inc.
California Pacific Medical Center Research Institute
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes
Inclusion criteria
* Male or female, aged 18 to 55. * Ability to give informed consent.
Exclusion criteria
* Unwilling or unable to access the web over a cell phone or living in an area with no cell phone service. * Any medical, psychiatric, or other condition that, in the opinion of the investigator, would preclude safe, consistent, or useful participation in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Comparison of neurocognitive task results | 2 weeks | Results collected using a web-based data collection platform will be comparable (but not necessarily equivalent) to data collected under controlled laboratory conditions. |
Countries
United States
Outcome results
None listed